Clinical Trial Update: Evaluation of Low Source of Signal in SCOUT DS

View source ↗

Summary

This update reports results from a completed VeraLight-sponsored trial evaluating SCOUT DS signal performance. The trial enrolled individuals with metabolic syn…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gestational Diabetes
• Impaired Glucose Tolerance
• Metabolic Syndrome

Snippet

Sponsor: VeraLight, Inc. | Conditions: Metabolic Syndrome, Impaired Glucose Tolerance | Status: COMPLETED